David M. Gustin

636 total citations
19 papers, 511 citations indexed

About

David M. Gustin is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David M. Gustin has authored 19 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Otorhinolaryngology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in David M. Gustin's work include Head and Neck Cancer Studies (8 papers), Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). David M. Gustin is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). David M. Gustin collaborates with scholars based in United States, France and Philippines. David M. Gustin's co-authors include Dean E. Brenner, William A. See, Robert Dreicer, Richard D. Williams, James A. Crowell, Maria Stacewicz‐Sapuntzakis, Keith A. Rodvold, Veda Diwadkar‐Navsariwala, Jeffery A. Sosman and Phyllis E. Bowen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Journal of Lipid Research.

In The Last Decade

David M. Gustin

19 papers receiving 497 citations

Peers

David M. Gustin
Jane H. Zhou United States
Tatiane De Rossi Brazil
Liviuţa Budişan Romania
A. Pfeifer Switzerland
Mario Falsaperla Italy
V. Bhuvarahamurthy India
T. Sugimura Japan
Kuei‐Li Lin Taiwan
Jane H. Zhou United States
David M. Gustin
Citations per year, relative to David M. Gustin David M. Gustin (= 1×) peers Jane H. Zhou

Countries citing papers authored by David M. Gustin

Since Specialization
Citations

This map shows the geographic impact of David M. Gustin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Gustin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Gustin more than expected).

Fields of papers citing papers by David M. Gustin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Gustin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Gustin. The network helps show where David M. Gustin may publish in the future.

Co-authorship network of co-authors of David M. Gustin

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Gustin. A scholar is included among the top collaborators of David M. Gustin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Gustin. David M. Gustin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gustin, David M.. (2004). Chemoprevention of head and neck cancer. Seminars in Oncology. 31(6). 769–777. 6 indexed citations
2.
3.
4.
Gustin, David M., Daniel J. Haraf, Kerstin Stenson, et al.. (2004). Treatment of advanced head and neck cancer with induction chemotherapy followed by chemoradiotherapy with reduced radiation dose. Journal of Clinical Oncology. 22(14_suppl). 5546–5546. 2 indexed citations
5.
Gustin, David M., Keith A. Rodvold, Jeffery A. Sosman, et al.. (2004). Single-Dose Pharmacokinetic Study of Lycopene Delivered in a Well-Defined Food-Based Lycopene Delivery System (Tomato Paste-Oil Mixture) in Healthy Adult Male Subjects. Cancer Epidemiology Biomarkers & Prevention. 13(5). 850–860. 60 indexed citations
6.
Gustin, David M., D. Haraf, F. Rosen, et al.. (2004). Treatment of advanced head and neck cancer with induction chemotherapy followed by chemoradiotherapy with reduced radiation dose. Journal of Clinical Oncology. 22(14_suppl). 5546–5546. 2 indexed citations
7.
Kane, Madeleine, Ezra E.W. Cohen, Bhoomi Mehrotra, et al.. (2004). Phase II study of 250 mg gefitinib in advanced squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 22(14_suppl). 5586–5586. 22 indexed citations
8.
Kane, Madeleine, Ezra E.W. Cohen, Bhoomi Mehrotra, et al.. (2004). Phase II study of 250 mg gefitinib in advanced squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 22(14_suppl). 5586–5586. 10 indexed citations
9.
Diwadkar‐Navsariwala, Veda, Janet A. Novotny, David M. Gustin, et al.. (2003). A physiological pharmacokinetic model describing the disposition of lycopene in healthy men. Journal of Lipid Research. 44(10). 1927–1939. 73 indexed citations
10.
Gustin, David M. & Dean E. Brenner. (2002). Chemoprevention of Colon Cancer: Current Status and Future Prospects. Cancer and Metastasis Reviews. 21(3-4). 323–348. 58 indexed citations
11.
Mata‐Greenwood, Eugenia, et al.. (2002). Brusatol-mediated induction of leukemic cell differentiation and G1 arrest is associated with down-regulation of c-myc. Leukemia. 16(11). 2275–2284. 72 indexed citations
12.
13.
Sosman, Jeffrey A., Amit Verma, Steven M. Moss, et al.. (2000). Interleukin 10-induced thrombocytopenia in normal healthy adult volunteers: evidence for decreased platelet production. British Journal of Haematology. 111(1). 104–111. 36 indexed citations
14.
Gustin, David M., et al.. (2000). Cold Agglutinin Disease in a Patient with Uterine Sarcoma. The American Journal of the Medical Sciences. 320(5). 352–354. 9 indexed citations
15.
Gustin, David M., et al.. (2000). Call Center Benchmarking: How Good Is. Purdue e-Pubs (Purdue University System). 4 indexed citations
16.
Sosman, Jeffrey A., Amit Verma, Steven M. Moss, et al.. (2000). Interleukin 10‐induced thrombocytopenia in normal healthy adult volunteers: evidence for decreased platelet production. British Journal of Haematology. 111(1). 104–111. 10 indexed citations
17.
Hoffman, Henry T., et al.. (1997). Organ Preservation Therapy for Advanced-Stage Laryngeal Carcinoma. Otolaryngologic Clinics of North America. 30(1). 113–130. 15 indexed citations
18.
Dreicer, Robert, David M. Gustin, William A. See, & Richard D. Williams. (1996). Paclitaxel in Advanced Urothelial Carcinoma. The Journal of Urology. 1606–1608. 1 indexed citations
19.
Dreicer, Robert, David M. Gustin, William A. See, & Richard D. Williams. (1996). Paclitaxel in Advanced Urothelial Carcinoma: Its Role in Patients with Renal Insufficiency and as Salvage Therapy. The Journal of Urology. 156(5). 1606–1608. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane H. Zhou Breakdown of academic impact, for papers by Tatiane De Rossi Breakdown of academic impact, for papers by Liviuţa Budişan Breakdown of academic impact, for papers by A. Pfeifer Breakdown of academic impact, for papers by Mario Falsaperla Breakdown of academic impact, for papers by V. Bhuvarahamurthy Breakdown of academic impact, for papers by T. Sugimura Breakdown of academic impact, for papers by Kuei‐Li Lin
Rankless by CCL
2026